Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » BPMA.OB: Benda Pharmaceutical: New Chinese Play » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
Duncan Idaho  - posted
Benda Pharmaceutical, Inc. Appoints Eric Yu Tak Shing as Its Chief Financial Officer
Monday February 12, 9:25 am ET

HUBEI PROVINCE, CHINA--(MARKET WIRE)--Feb 12, 2007 -- Benda Pharmaceutical, Inc. ("Benda" or the "Company") (OTC BB:BPMA.OB - News), a Chinese-based pharmaceutical company engaged in the development, manufacturing and distribution of medicines, active pharmaceutical ingredients and pharmaceutical intermediaries, announced today the appointment of Eric Yu Tak Shing as Chief Financial Officer effective February 9, 2007. Mr. Yu is a certified public account (CPA, Hong Kong and CPA, Australia) with 13 years of experience in public and corporate accounting and finance, most recently as Financial Controller of Beijing Teletron Telecom Engineering Co., Ltd. Mr. Yu began his career in 1993 with BDO Kwan Wong Tan & Fong, which was acquired by Deloitte Touche Tohmatus in 1996. He has held progressively more responsible positions with companies in China, Hong Kong, Australia and the United States, gaining in-depth knowledge and understanding of the accounting procedures, standards and issues in accordance with PRC GAAP, US GAAP and Hong Kong GAAP. Mr. Yu is fluent in English, Mandarin and Cantonese. He holds a Bachelor of Commerce Degree in Accountancy and Legal Studies from the University of Wollongong in Australia.

"Benda Pharmaceutical is deeply committed to fulfilling its corporate responsibilities as a U.S. public company," said Benda CEO, Yiqing Wan. "The appointment of Mr. Yu as Benda's Chief Financial Officer is an important milestone and one essential to that effort. His intimate knowledge of U.S. GAAP and the U.S. capital markets will help us develop the rigorous discipline in our corporate governance, financial reporting and investor communications that will be required on our path to eventually becoming a NASDAQ listed stock."
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share